My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Bayer to acquire Monsanto in all cash transaction

Bayer to acquire Monsanto in all cash transaction

Sep 14,2016

Monsanto India announced that Bayer and Monsanto signed definitive agreement under which Bayer will acquire Monsanto for USD 128 per share in an all cash transaction.

Powered by Capital Market - Live News

Canara Bank director retires
Jun 01,2017

Canara Bank announced that Harideesh Kumar B, Executive director of the Bank has retired from the services of the Bank on 31 May 2017 on attaining the age of superannuation.

Powered by Capital Market - Live News

NLC India extends Wednesdays rally
Jun 01,2017

Meanwhile, the S&P BSE Sensex was up 2.81 points, or 0.01% at 31,148.61.

On the BSE, 43,000 shares were traded on the counter so far as against the average daily volumes of 75,250 shares in the past one quarter. The stock had hit a high of Rs 108.90 and a low of Rs 105.50 so far during the day.

The stock had hit a 52-week high of Rs 123 on 23 March 2017 and a 52-week low of Rs 68.05 on 3 June 2016. The stock had underperformed the market over the past one month till 31 May 2017, gaining 0.09% compared with the Sensexs 4.1% rise. The scrip had, however, outperformed the market over the past one quarter advancing 14.35% as against the Sensexs 8.36% rise.

The large-cap company has equity capital of Rs 1528.75 crore. Face value per share is Rs 10.

Shares of NLC India have rallied 8.45% in the two trading sessions from its close of Rs 99.35 on 30 May 2017, after the company after market hours on Tuesday, 30 May 2017 reported strong Q4 March 2017 results. The stock had surged 6.29% to settle at Rs 105.60 yesterday, 31 May 2017.

NLC Indias net profit surged 277.9% to Rs 1501.47 crore on 55.2% increase in net sales to Rs 2841.86 crore in Q4 March 2017 over Q4 March 2016.

NLC India operates lignite mines, pithead thermal power stations and also has operations in renewable energy sector.

As per the shareholding pattern as on 31 March 2017, the Government of India held 89.33% stake in the company.

Powered by Capital Market - Live News

Jetking Infotrain approves reissue of forfeited shares
Jun 01,2017

The board of Jetking Infotrain on 30th May 2017 has approved the re-issue of 18,500 forfeited Equity shares of the Company on Preferential Basis subject to approval of the members of the Company by the means of special resolution at the ensuing Annual General Meeting.

Powered by Capital Market - Live News

Strides Shasun takes a big stride after USFDA nod for drug
Jun 01,2017

The announcement was made during market hours today, 1 June 2017.

Meanwhile, the S&P BSE Sensex was down 4.84 points, or 0.02%, to 31,141.10. The S&P BSE Mid-Cap index was up 69.18 points, or 0.47%, to 14,694.47.

On the BSE, 41,451 shares were traded in the counter so far, compared with average daily volume of 58,757 shares in the past one quarter. The stock had hit a high of Rs 950.50 and a low of Rs 903.05 so far during the day. The stock had hit a 52-week high of Rs 1,259 on 3 February 2017. The stock had hit a 52-week low of Rs 848.50 on 24 May 2017.

The stock had underperformed the market over the past one month till 31 May 2017, falling 15.51% compared with 4.1% gains in the Sensex. The scrip had also underperformed the market in past one quarter, dropping 22.12% as against Sensexs 8.36% gains. The scrip had also underperformed the market in past one year, declining 18.65% as against Sensexs 16.79% gains.

The mid-cap company has equity capital of Rs 89.42 crore. Face value per share is Rs 10.

Strides Shasun announced that it has received approval from the United States Food & Drug Administration (USFDA) for Ibuprofen Tablets USP, 200 mg (OTC).

According to IRi data, the annual US market for Ibuprofen Tablets USP 200 mg (OTC) is about $520 million. The product will be marketed by Strides Pharma Inc in the US market under its OTC brand Nuprin.

Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, muscle aches or arthritis. It is also used to reduce fever and to relieve minor aches and pain due to the common cold or flu. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID).

Strides Shasuns consolidated net profit spurted 2877.4% to Rs 131.9 crore on 3.9% fall in net sales to Rs 888.41 crore in Q4 March 2017 over Q4 March 2016.

Strides Shasun is a vertically integrated global pharmaceutical company headquartered in Bangalore.

Powered by Capital Market - Live News

Healthfore Technologies Company Secretary resigns
Jun 01,2017

Healthfore Technologies announced that Shikha Rastogi Company Secretary & Compliance Officer of the Company has tendered her resignation effective from close of business hours on May 31, 2017.

Powered by Capital Market - Live News

Maruti slips on profit booking after announcing monthly sales
Jun 01,2017

Meanwhile, the S&P BSE Sensex was up 8.42 points or 0.03% at 31,154.23.

On the BSE, 29,000 shares were traded on the counter so far as against the average daily volumes of 65,542 shares in the past one quarter. The stock hit a high of Rs 7,249.30 in intraday trade so far, which is record high for the counter. The stock had hit a low of Rs 7,142 so far during the day. The stock had hit a 52-week low of Rs 3,868.10 on 24 June 2016.

The stock had outperformed the market over the past one month till 31 May 2017, rising 7.59% compared with 4.1% gains in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 21.9% as against Sensexs 8.36% gains. The scrip had also outperformed the market in past one year, surging 73.37% as against Sensexs 16.79% gains.

The large-cap company has equity capital of Rs 151.04 crore. Face value per share is Rs 5.

Maruti Suzuki Indias total sales rose 11.3% to 1.36 lakh units in May 2017 over May 2016. Domestic sales grew by 15.5% to 1.30 lakh units in May 2017 over May 2016. Export sales declined 36.3% to 6,286 units in May 2017 over May 2016. The announcement was made during market hours today, 1 June 2017.

Marutis net profit rose 15.77% to Rs 1709 crore on 20.32% growth in net sales to Rs 18005.20 crore in Q4 March 2017 over Q4 March 2016.

Maruti Suzuki India is Indias biggest car maker in terms of market share. Japanese parent Suzuki Motor Corporation currently holds 56.21% stake in Maruti Suzuki India (as per the shareholding pattern as on 31 March 2017).

Powered by Capital Market - Live News

Emmsons International changes management
Jun 01,2017

The Board of Emmsons International on 30th May 2017 has approved the appointment of Bhalendra Pal Singh as Chief Financial Officer of the Company to be designated as the Key Managerial Personnel w.e.f. 30 May 2017.

Powered by Capital Market - Live News

Claris undergoes USFDA Audit
Jun 01,2017

Claris Lifesciences along with its wholly owned subsidiary Claris Injectables announced that its underwent a successful USFDA Pharmacovigilance audit from 29th May to 31st May with No Observations.

Powered by Capital Market - Live News

Claris Life gets healthier after USFDAs successful audit
Jun 01,2017

The announcement was made during market hours today, 1 June 2017. The stock has snapped two-day losing streak.

Meanwhile, the S&P BSE Sensex was up 20.60 points, or 0.07%, to 31,166.40. The S&P BSE Small-Cap index was up 136.94 points, or 0.91%, to 15,217.15.

On the BSE, 12,568 shares were traded on the counter so far as against the average daily volumes of 81,022 shares in the past one quarter. The stock had hit a high of Rs 338 and a low of Rs 327.90 so far during the day.

The stock hit a record high of Rs 430.10 on 16 December 2016. The stock hit a 52-week low of Rs 188 on 24 June 2016.

The stock had underperformed the market over the past one month till 31 May 2017, falling 7.7% compared with 4.1% gains in the Sensex. The scrip had also underperformed the market in past one quarter, gaining 2.32% as against Sensexs 8.36% gains. The scrip had, however, outperformed the market in past one year, gaining 49.89% as against Sensexs 16.79% gains.

The small-cap company has an equity capital of Rs 54.57 crore. Face value per share is Rs 10.

Claris Lifesciences (CLL) along with its wholly owned subsidiary Claris Injectables (CIL) announced that it underwent a successful United States Food & Drug Administration (USFDA) Pharmacovigilance (PV) audit from 29th May to 31st May 2017, with no observation (i483s).

Claris Lifesciences reported consolidated net profit of Rs 36.96 crore in Q4 March 2017 compared with net loss of Rs 0.62 crore in Q4 March 2016. Net sales fell 75.8% to Rs 4.41 crore in Q4 March 2017 over Q4 March 2016.

Claris Lifesciences is holding company of Claris Injectables, a wholly-owned subsidiary dealing in specialty injectables business. It is also the holding company of Claris Otsuka Private Limited, a joint venture with Japans Otsuka Pharmaceutical Factory, Inc. and Mitsui & Co. for Infusion business in India and emerging markets.

Powered by Capital Market - Live News

IIFL Holdings changes directorate
Jun 01,2017

IIFL Holdings announced its material subsidiary India Infoline Finance Limited has appointed Shubhalakshmi Panse as an Independent Director with the effect from 31 May 2017.

Powered by Capital Market - Live News

Escorts announces tractors sales performance
Jun 01,2017

Escorts announced that Agri Machinery Segment (EAM) in May 2017 sold 6,770 tractors in domestic market growth of 29% against 5,252 tractors in May 2016.

Export for the month of May 2017 at 116 tractors up by 47% against 79 tractors in May 2016.

Total (Domestic + Exports) tractor sales in May 2017 at 6,886 tractors up by 29% against 5,331 tractors in May 2016.

Powered by Capital Market - Live News

Indian Oil Corporation changes directorate
Jun 01,2017

Indian Oil Corporation has announced Sanjiv Singh, Director (Refineries) has been appointed as the Chairman of the Company and has assumed charge with effect from 1st June 2017 on account of superannuation of the incumbent Chairman B Ashok on 31st May 2017.

Powered by Capital Market - Live News

Sharda Motor hits record high after strong Q4 results
Jun 01,2017

Meanwhile, the S&P BSE Sensex was up 20.11 points, or 0.06% at 31,165.91. The S&P BSE Small-Cap index was up 125.56 points, or 0.83% at 15,205.77.

High volumes were traded on the counter. On the BSE, 14,000 shares were traded on the counter so far as against the average daily volumes of 1,990 shares in the past one quarter. The stock had hit a high of Rs 2,408 so far during the day, which is also its record high. The stock had hit a low of Rs 2,220 so far during the day.

The stock had hit a 52-week low of Rs 801.05 on 24 June 2016. The stock had outperformed the market over the past one month till 31 May 2017, advancing 11.98% compared with the Sensexs 4.1% rise. The scrip had also outperformed the market over the past one quarter advancing 58.14% as against the Sensexs 8.36% rise.

The small-cap company has equity capital of Rs 5.95 crore. Face value per share is Rs 10.

Shares of Sharda Motor Industries company have rallied 28.14% in the two trading sessions from its close of Rs 1,787.45 on 30 May 2017, after the company after market hours on Tuesday, 30 May 2017 reported strong Q4 March 2017 results. The stock had surged 20% to settle at Rs 2,144.90 yesterday, 31 May 2017.

Sharda Motor Industries net profit spurted 131.79% to Rs 19.47 crore on 14.71% increase in total revenue to Rs 291.11 crore in Q4 March 2017 over Q4 March 2016.

Sharda Motor Industries operates in the automotive industry. The company is one of the leading manufacturers of exhaust systems, suspension systems, seat trim and seat frames.

Powered by Capital Market - Live News

Dena Bank to hold AGM
Jun 01,2017

Dena Bank announced that the 21st Annual General Meeting of the bank will be held on 27 June 2017.

Powered by Capital Market - Live News

Combination of push & pull factors can help India become global hub for electronics manufacturing: P.P. Chaudhary
Jun 01,2017

A combination of push and pull factors like minimum professional charges, low manufacturing costs together with huge population and vast geographical area can work in favour of India and help it become global hub for electrical and electronics manufacturing sector, Union Minister, Mr P.P. Chaudhary said at an ASSOCHAM event.

n++Two push and pull factors are working in favour of India and the complete ecosystem has been generated, the pull factor is looking at the 1.25 billion population and the vast area as such every company intends to invest in this country,n++ said Mr Chaudhary.

n++The push factor is that all across the globe, while per hour professional and engineering charges come to more than $3.5 but in India it is less than even $1,n++ added Mr Chaudhary.

n++So this is a place where these two factors, pull and push can work in favour of India and above all, the overall cost for creating the manufacturing hub here is much less than in other parts of the world,n++ he said further.

The Union Minister also stressed upon the need for India to promote research and development to stay ahead and keep abreast of technology in this digital age.

n++There is a need for developing a commercially viable research ecosystem funded by the government, industry and academia to promote the next wave of electronic technology in the country and innovations in our journey to becoming a developed nation,n++ said Mr Chaudhary.

He said considering that demand for electronic hardware in India is projected to increase from $45 billion in 2009 to $400 billion by 2020 it represents huge opportunity for making investments and attaining huge growth in electronics manufacturing sector.

Ministry of Electronics and IT has initiated various schemes like MSIPS, EMCs, ITIR, EDF and others to attract global companies to set up their manufacturing base in India.

n++The inherent objective of these policies and schemes is to bring about a fundamental shift in the nature of foreign investments coming to the country rather than being just a low-cost manufacturing destination,n++ said Mr Chaudhary.

n++India is acknowledged as a true partner which adds significant value in production cycle of these products,n++ he added.

He informed that the Union Government has also amended its general financial rules and made special provision for its digital procurement platform, government e-market place to give a boost to the start-ups and for local manufacturing of goods and services in the country.

Highlighting that availability of skilled manpower is another pre-requisite for developing robust manufacturing ecosystem in the country, Mr Chaudhary said, n++Under the Digital India programme, my Ministry has initiated a scheme for skill development in ESDM sector which shall cover all the state and UTs of the country in order to facilitate creation of an ecosystem for development of ESDM.n++

The Minister further said that the government is ensuring time-bound and mission mode implementation of various programmes and initiatives like - Digital India, Make in India, Swachh Bharat, Start-Up India, Stand-Up India, Jan-Dhan Yojana and others at an unprecedented scale and speed.

Powered by Capital Market - Live News